Condition: Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) · Sponsor: CSL Behring
A randomized, open-label, prospective, multicenter study designed to investigate 2 dose levels in pediatric subjects 2 to ≤ 17 years of age with confirmed or possible CIDP, either previously exposed to IVIG treatment or unexposed to IVIG treatment
This description comes directly from the study's public registry record.
Trial Registration Coordinator · 6108784697 · clinicaltrials@cslbehring.com
Always discuss trial participation with your own doctor first.
| Phoenix Children's Hospital | Phoenix, Arizona, United States | Completed |
| Children's Hospital of Los Angeles | Los Angeles, California, United States | Withdrawn |
| University of Iowa Hospitals and Clinics | Iowa City, Iowa, United States | Withdrawn |
| Akron Children's Hospital | Akron, Ohio, United States | Withdrawn |
| Children's Hospital of Philadelphia | Philadelphia, Pennsylvania, United States | Recruiting |
| Le Bonheur Children's Hospital | Memphis, Tennessee, United States | Withdrawn |
| Neurology Rare Disease Center | Flower Mound, Texas, United States | Recruiting |
| Children's Specialty Group | Norfolk, Virginia, United States | Completed |
| Seattle Children's Hospital | Seattle, Washington, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03684018